President of German biotechnology industry association elected chairman of international umbrella organization
President of German biotechnology industry association elected chairman of international umbrella organization
(Berlin - June 29, 2022) At the world's largest biotechnology trade show, the BIO Convention in San Diego, the president of the German biotechnology industry association BIO Deutschland was elected Chairman of the Board of the International Council of Biotechnology Associations (ICBA). Oliver Schacht, who was previously Vice President of ICBA, takes over from Steve Bates of the UK Bioindustry Association for the next two years.
Oliver Schacht comments, "I would like to thank the international biotech community for their confidence in me and look forward to my new role as Chair of the International Council of Biotechnology Associations. Many issues that are important for our innovative industry do not end at national borders, but can only be meaningfully advanced through international exchange and global collaboration, for example patent protection for innovations or the fight against antibiotic resistance. This is why ICBA is so important, alongside national associations. I will work to further expand international cooperation and further strengthen the position of the global biotechnology industry. Because with global cooperation, biotechnology has the potential to master the great challenges of our time if we shape the framework conditions correctly."
The International Council of Biotechnology Associations (ICBA) has been in existence since 2014. It is an association of national biotechnology industry associations that aims to promote public understanding of biotechnology and advocate for policies that support the growth of the innovative biotechnology industry. ICBA represents the global voice of the industry in international bodies with the goal of promoting continued innovation in human health, agriculture, industry and the environment. BIO Deutschland is a founding member of ICBA. The total 30 members of ICBA are:
Japan BioIndustry Association (JBA) - Japan, Africa BIO - South Africa, Association of Biotech-Led Enterprises (ABLE) - India, AusBiotec - Australia, Bio. be/Essencia - Belgium, BioPharmaChem Ireland - Ireland, BIOTECanada - Canada, BIOTech New Zealand (BIOTechNZ) - New Zealand, Biotechnology Innovation Organization (BIO) - United States, CRbiomed - Costa Rica, Czech Bio - Czech Republic, EuropaBio - Europe, Finnish BioIndustries - Finland, Foro Argentino de Biotecnologia - Argentina, France Biotech - France, German Association of Biotechnology Industries (DIB) - Germany, Holland Bio - Holland, Hong Kong Biotechnology Association - Hong Kong, Hungarian Biotechnology Association - Hungary, Italian Association for the Development of Biotechnology (Assobiotec) - Italy, KoreaBIO - South Korea, PeruBiotec - Peru, Portugal's Biotechnology Industry Organization (P-BIO) - Portugal, SwedenBIO - Sweden, Swiss Biotech Association (SBA) - Switzerland, Taiwan Bio Industry Association - Taiwan, The Greek Initiative on the Bioeconomy - Greece, The Spanish Bioindustry Association (ASEBIO) - Spain,
UK BioIndustry Association (BIA) - United Kingdom and BIO Deutschland - Germany.
Further information on ICBA can be found here: https://internationalbiotech.org
439 words/3083 characters including spaces
About BIO Deutschland:
BIO Deutschland e. V., with more than 370 members – companies, BioRegions and industry service providers – and headquartered in Berlin, Germany, aims to support and promote the development of an innovative economic sector in Germany based on modern life sciences. Oliver Schacht, Ph. D., is chairman of the board of BIO Deutschland.
For more information, visit: www.biodeutschland.org
Supporting members of BIO Deutschland and industry partners are:
AGC Biologics, Avia, AWS, Baker Tilly, Bayer, BioSpring, Boehringer Ingelheim, Centogene, Clariant, CMS Hasche Sigle, Deutsche Bank, Ernst & Young, Evotec, Janssen-Cilag, KPMG, Lonza, Merck, Miltenyi Biotec, MorphoSys, Novartis, Pfizer, PricewaterhouseCoopers, QIAGEN, Rentschler Biopharma, Roche Diagnostics, Sanofi Aventis Deutschland, SAP, Schmidt Versicherungs Treuhand AG, Simmons & Simmons, Springer Nature, Thermo Fisher Scientific, TVM Life Sciences Management, Vertex Pharmaceuticals, ZETA.
Contact:
BIO Deutschland e. V.
Dr Claudia Englbrecht
Schützenstraße 6a
10117 Berlin, Germany
Tel.: +49 30 2332 164-32
Mobile: +49 151 1406 7326
Email: englbrecht@biodeutschland.org
Publication free of charge – specimen copy requested.
